The PTX200 Breast cancer Phase2 trial is an extensive multi-year program on 34 patients.
If we get positive results here, fair to say PTX will re-rate to same level as NASDAQ peers...
What is that worth?
Many, many multiples of where we are now.
Then there are the AML and Ovarian cancer Phase 1b results.
Not to mention PTX100 results in Q1 2020.
Exciting times.
The PTX200 Breast cancer Phase2 trial is an extensive multi-year...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.001(1.75%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.5¢ | $45.94K | 831.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 156326 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 101860 | 1 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.5¢ | 83043 | ||
| Last updated 15.59pm 25/04/2024 ? | |||||
| PTX (ASX) Chart |